Navigation Links
DiaLog Signs Agreement with DeliverMed to Improve Diabetic Patient Management
Date:7/29/2008

WILMINGTON, N.C., July 29 /PRNewswire/ -- DiaLog, Inc., a wholly owned subsidiary of Inclinix, Inc., signed a joint agreement with DeliverMed Holdings, LLC, an Illinois-based, diabetes specialty home delivery pharmacy. DiaLog's featured product, the DiaLog System, promotes compliance and adherence to blood glucose testing to help diabetic patients and their physicians better manage their disease. DeliverMed complements the DiaLog System as a leading delivery supplier of prescription medications and glucose testing supplies across the U.S.

The DiaLog System and DeliverMed's services will give physicians the single source for glucose monitoring results and prescription fulfillment information to measure patient compliance and progress. Use of the DiaLog System by DeliverMed's patients will result in enhanced compliance to prescribed therapies, improved patient outcomes and related cost savings.

The CDC recently reported nearly 24 million people in the U.S. suffer from diabetes, an increase of more than three million in two years. With this rapidly growing prevalence, it is critical to the U.S. health system to provide effective tools to better manage the disease. The DiaLog System and DeliverMed's home delivery service will provide patients a "one source" for glucose monitoring, prescription fulfillment and patient education.

Jeff Bagshaw, President of DiaLog and Senior VP of Inclinix stated, "DiaLog is a powerful, convenient system for patients and physicians to improve the quality of life for diabetic patients. The addition of DeliverMed to the DiaLog system will allow us to provide easily accessible prescription drugs and supplies to diabetics."

About DeliverMed

Founded in 1998, DeliverMed provides prescription medications and glucose testing supplies to the homes of individuals suffering from diabetes and other chronic conditions. DeliverMed combines the latest in pharmacy robotic technology with old-fashioned personal customer service to provide the highest quality patient care. DeliverMed provides its services at no additional cost to either patients or insurers. For more information on DeliverMed, contact CEO, Mark A. Swift.

About Inclinix

Founded in 1999, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. Inclinix delivers customized marketing solutions that yield improved market penetration and adherence results. In the pharmaceutical development arena, Inclinix is a contract research organization that supports and manages clinical drug trials and patient recruitment. For more information about Inclinix, visit http://www.inclinix.com .

Press Contacts:

Mark A. Swift

DeliverMed

Chief Executive Officer

312.543.5450

delivermed@yahoo.com

Jeff Bagshaw

Inclinix

Senior VP of Inclinix

910.332.2066

jbagshaw@inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Coalition to Prevent Deep-Vein Thrombosis (DVT) Seeks New Icon to Raise Awareness and Increase Dialogue
2. Online tool supports more dialogue on prostate cancer risk
3. Health Dialog and Independence Blue Cross Extend Relationship, Expand Services
4. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
5. Free Site Offering Patient-Physician Dialog Reaches Milestone
6. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
7. Data Dialog Marketing Expands Sales Management Team
8. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
9. Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions
10. iNutrition Signs John OHurley to Launch New Internet Video Campaign
11. Huntsville Hospital Signs With Health Care Systems, Inc. for Automated Medication Reconciliation Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: